← Open Payments lookup

COLLEEN KARASINSKI: Open Payments

NPI 1013171206 · SOMERS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,443 in 36 payments from 7 companies in 2025. Trend: 2023 $950 · 2024 $915 · 2025 $1,443

Food & beverage: $1,443
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$583
Neurocrine BioSciences, Inc.4$275
Axsome Therapeutics, Inc.4$250
Otsuka America Pharmaceutical, Inc.9$216
Alkermes, Inc.4$70
ABBVIE INC.2$32
Takeda Pharmaceuticals U.S.A., Inc.1$18

Products named: CAPLYTA, INGREZZA, Auvelity, REXULTI, VIVITROL, VRAYLAR, TRINTELLIX, ARISTADA.

Industry payments across NJ — which companies pay providers there.